Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
Prospects for cannabinoid therapies in basal ganglia disorders
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease
Cannabidiol for the treatment of psychosis in Parkinson’s disease
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease
Therapeutic potential of cannabinoids in CNS disease
Solar theme designed by epicShops